Hepatitis B
138 results
1 - 100
Hepatitis B- PATHOGENS
- CLINICAL
- DIAGNOSIS
- TREATMENT
- Goals of Therapy
- Criteria for Starting Therapy (among HIV+)
- Monitoring Therapy
- Criteria for Stopping Therapy
- HBV Therapies
- Treatment Categories
- Use of ART in HIV-HBV Co-infected
- Other Recommendations for Chronic HBV Co-infection
- Prevention
- Selected Drug Comments
- Pathogen Specific Therapy
- Basis for recommendation
- References
- Hepatitis B (HBV) vaccines
- Entecavir
- Amphotericin B
- Simeprevir
- Tenofovir alafenamide (TAF)
- Rilpivirine
- Dolutegravir
- Cobicistat
- Viekira Pak
- Glecaprevir + Pibrentasvir
- Sofosbuvir + Ledipasvir
- Nirmatrelvir/Ritonavir
- Tipranavir
- Adefovir
- Nevirapine
- Voriconazole
- Rotavirus vaccine
- Nelfinavir
- Telbivudine
- Bictegravir
- Sofosbuvir
- Doravirine
- Delstrigo
- Elvitegravir
- Interferon alfa
- Emtricitabine
- Elbasvir/Grazoprevir
- Lenacapavir
- Letermovir
- Tenofovir DF
- Etravirine (ETR)
- Hepatitis A vaccine (HAV)
- COVID-19 Convalescent Plasma
- HIV Solid Organ Transplant Candidate/Recipient
- HIV, Occupational Exposure
- Intravenous immune globulin
- Haemophilus influenzae (Hib) vaccine
- Hepatotoxicity
- Measles vaccines
- Rubella vaccine
- Toxicity & side effects: switching therapy
- Peliosis hepatis
- Mumps vaccine
- Cryptococcal Meningitis
- Hepatitis C
- Hepatitis A
- Nephropathy, HIV-Associated (HIVAN)